SUPN
#1842
Supernus Pharmaceuticals, Inc. - Common Stock
44.1 9 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.54%
Monthly Change
-6.81%
6 month change
-18.15%
Year Change
-18.17%
Previous Close
44.8 8
Open
44.1 9
Low
44.1 9
High
44.1 9
Volume
46
Financials
- Market Capitalization 2.57 B
- Employee 778
- Founded 2005
- CEO Jack A. Khattar
- Website www.supernus.com
- Headquarter Delaware, United States
- FIGI BBG000BP0HX7
- Industry Drug Manufacturers—Specialty & Generic
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-24.22
Price to sales ratio
3.2
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1497 |  INDV Indivior Pharmaceuticals, Inc. - Common Stock | 35.30 USD | -1.48% | -6.32% | -14.49% | +5.06% | 4.17 B USD | ||
| 1800 |  RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.52 USD | +0.36% | +1.47% | -7.54% | -62.90% | 2.73 B USD | ||
| 1883 |  PBH Prestige Consumer Healthcare Inc. Common Stock | 51.19 USD | -1.97% | +2.09% | -0.58% | -24.14% | 2.43 B USD | ||
| 1901 |  BHC Bausch Health Companies Inc. Common Stock | 6.30 USD | -3.23% | -6.67% | +37.55% | -11.64% | 2.36 B USD |
Frequently asked questions about Supernus Pharmaceuticals, Inc.
What is the Supernus Pharmaceuticals, Inc. stock price today?
The current price of Supernus Pharmaceuticals, Inc. (SUPN) is 44.19. Over the past 24 hours, the stock has changed by -1.54%. Follow the SUPN chart for real-time price dynamics.
What is the stock ticker of Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. trades under the ticker SUPN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Supernus Pharmaceuticals, Inc. stock going up?
SUPN has changed by -5.84% over the last week, -6.81% over the last month, and -18.17% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. currently has a market capitalization of 2.57 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Supernus Pharmaceuticals, Inc. earnings last quarter?
Last quarter, Supernus Pharmaceuticals, Inc. reported earnings of -1.01 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Supernus Pharmaceuticals, Inc. revenue for the last quarter?
Supernus Pharmaceuticals, Inc. reported quarterly revenue of 219.06 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Supernus Pharmaceuticals, Inc. net income for the last quarter?
Supernus Pharmaceuticals, Inc. reported net income of -58.37 M for the last quarter. The previous quarter showed -2.29 M, which means net income changed by -2445.62%.
How many employees does Supernus Pharmaceuticals, Inc. have?
As of the latest available data, Supernus Pharmaceuticals, Inc. has 778 employees. Workforce size can provide additional context about the company's scale and operations.
What is Supernus Pharmaceuticals, Inc. EBITDA?
Supernus Pharmaceuticals, Inc. EBITDA is -32.22 M, and its EBITDA margin is -14.71%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Supernus Pharmaceuticals, Inc. stock?
You can buy Supernus Pharmaceuticals, Inc. (SUPN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Supernus Pharmaceuticals, Inc. stock?
Investing in Supernus Pharmaceuticals, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SUPN chart and related analysis on metatrader.com as part of your research.